Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Bacteriological relevance of linezolid vs. vancomycin in postoperative empirical treatment of osteoarticular infections: a retrospective single-center study.

Takoudju E, Bémer P, Touchais S, Asseray N, Corvec S, Khatchatourian L, Serandour N, Boutoille D; Nantes Bone and Joint Infections Study Group.

Int J Antimicrob Agents. 2018 Nov;52(5):663-666. doi: 10.1016/j.ijantimicag.2018.04.022. Epub 2018 May 9.

PMID:
29751119
2.

Bacterial epidemiology of osteoarticular infections in a referent center: 10-year study.

Titécat M, Senneville E, Wallet F, Dezèque H, Migaud H, Courcol RJ, Loïez C.

Orthop Traumatol Surg Res. 2013 Oct;99(6):653-8. doi: 10.1016/j.otsr.2013.02.011. Epub 2013 Aug 27.

3.

[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].

Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A.

Acta Chir Orthop Traumatol Cech. 2006 Oct;73(5):329-33. Czech.

PMID:
17140514
4.

[DISTRIBUTION AND DRUG SENSITIVITY OF PATHOGENS IN PATIENTS WITH PROSTHETIC JOINT INFECTION AFTER PRIMARY TOTAL KNEE ARTHROPLASTY].

Yang Y, Yang F, Zhang Z, Li H, Chen J.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014 Jul;28(7):848-52. Chinese.

PMID:
26462348
5.
6.

Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.

Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB; Linezolid Pediatric Study Group.

Pediatr Infect Dis J. 2003 Aug;22(8):677-86.

PMID:
12913766
7.

Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.

Decousser JW, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, Cattoir V, Vandenesh F, Doucet-Populaire F; Microbs Study Group.

Int J Antimicrob Agents. 2015 Dec;46(6):622-30. doi: 10.1016/j.ijantimicag.2015.07.022. Epub 2015 Sep 25.

PMID:
26453147
8.

Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.

Patel K, Kabir R, Ahmad S, Allen SL.

J Oncol Pharm Pract. 2016 Apr;22(2):212-8. doi: 10.1177/1078155214556523. Epub 2014 Oct 17.

PMID:
25326010
9.
10.

Epidemiology of nosocomial pneumonia in infants after cardiac surgery.

Tan L, Sun X, Zhu X, Zhang Z, Li J, Shu Q.

Chest. 2004 Feb;125(2):410-7.

PMID:
14769717
11.
12.

Efficacy of linezolid, teicoplanin, and vancomycin in prevention of an experimental polytetrafluoroethylene graft infection model caused by methicillin-resistant Staphylococcus aureus.

Mese B, Bozoglan O, Elveren S, Eroglu E, Gul M, Celik A, Ciralik H, Yildirimdemir HI, Yasim A.

Med Sci Monit. 2015 Mar 27;21:909-14. doi: 10.12659/MSM.893098.

13.

In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections.

Littorin C, Hellmark B, Nilsdotter-Augustinsson Å, Söderquist B.

Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1549-1552. doi: 10.1007/s10096-017-2966-z. Epub 2017 Mar 22.

14.

Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting.

Nicoletti G, Schito G, Fadda G, Boros S, Nicolosi D, Marchese A, Spanu T, Pantosti A, Monaco M, Rezza G, Cassone A, Garaci E; CIGAR (Gruppo Cooperativo Infezioni Gravi ed Antibiotico Resistenza).

J Chemother. 2006 Dec;18(6):589-602. Erratum in: J Chemother. 2007 Oct;19(5):602-3.

PMID:
17267336
15.

Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.

Ghosh A, Karmakar PS, Pal J, Chakraborty N, Debnath NB, Mukherjee JD.

J Indian Med Assoc. 2009 Jan;107(1):21-2, 24-5.

PMID:
19588683
16.

Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.

Casellas JM, Tomé G, Bantar C, Bertolini P, Blázquez N, Borda N, Couto E, Cudmani N, Guerrera J, Juárez MJ, López T, Littvik A, Méndez E, Notario R, Ponce G, Quinteros M, Salamone F, Sparo M, Sutich E, Vaylet S, Wolff L.

Diagn Microbiol Infect Dis. 2003 Nov;47(3):527-37.

PMID:
14596972
17.

[Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].

Gong YL, Yang ZC, Yin SP, Liu MX, Zhang C, Luo XQ, Peng YZ.

Zhonghua Shao Shang Za Zhi. 2016 Sep 20;32(9):529-35. doi: 10.3760/cma.j.issn.1009-2587.2016.09.004. Chinese.

PMID:
27647068
18.

Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.

Lundstrom TS, Sobel JD.

Infect Dis Clin North Am. 2000 Jun;14(2):463-74. Review.

PMID:
10829266
19.

[Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].

Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.

Rev Esp Quimioter. 2012 Mar;25(1):25-30. Spanish.

Supplemental Content

Support Center